• Merus Licenses ENHANZE Drug Delivery Technology Of Halozyme Therapeutics Nasdaq Mon, 17 Nov 2025 13:16:00 GMT
• Merus and Halozyme partner on subcutaneous cancer drug delivery By Investing.com Investing.com South Africa Mon, 17 Nov 2025 12:13:16 GMT
• Merus and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab PR Newswire Mon, 17 Nov 2025 12:00:00 GMT
• How Halozyme Therapeutics Inc. (RV7) stock behaves in tightening cycles - Portfolio Gains Report & Daily Technical Stock Forecast ... newser.com Mon, 17 Nov 2025 09:37:21 GMT
• Why Halozyme Therapeutics Inc. stock is in analyst buy zone - Portfolio Performance Report & Entry Point Confirmation Signals newser.com Mon, 17 Nov 2025 07:59:10 GMT
• How Halozyme Therapeutics Inc. (RV7) stock behaves in tightening cycles - Trade Ideas & Daily Stock Momentum Reports newser.com Sun, 16 Nov 2025 21:01:57 GMT
• Will Halozyme Therapeutics Inc. price bounce be sustainable - July 2025 Summary & Trade Opportunity Analysis Reports newser.com Sun, 16 Nov 2025 17:22:48 GMT
• Strategies to average down on Halozyme Therapeutics Inc. - 2025 Institutional Moves & Fast Exit Strategy with Risk Control newser.com Sun, 16 Nov 2025 08:28:25 GMT
• is halozyme therapeutics inc. (rv7) stock good for long term investing - 2025 endofyear setup & trade opportunity analysis newser.com Sun, 16 Nov 2025 07:28:21 GMT
• Is Halozyme Therapeutics Inc. (RV7) stock nearing a technical breakout - Market Sentiment Report & AI Forecast for Swing Trade Pic... newser.com Sun, 16 Nov 2025 07:17:28 GMT
• halozyme therapeutics inc stock analysis and forecast - sector performance drivers & fast growing trading ideas earlytimes.in Sun, 16 Nov 2025 00:28:34 GMT
• Is Halozyme Therapeutics Inc. (RV7) stock nearing a technical breakout - Rate Cut & Real-Time Volume Analysis Alerts newser.com Sat, 15 Nov 2025 22:23:17 GMT
• is halozyme therapeutics inc. (rv7) stock good for long term investing - market movement recap & free low drawdown momentum trade ... newser.com Sat, 15 Nov 2025 21:27:06 GMT
• How Halozyme Therapeutics Inc. (RV7) stock reacts to stronger dollar - 2025 Support & Resistance & Free Technical Pattern Based Bu... newser.com Sat, 15 Nov 2025 18:34:32 GMT
• Why Halozyme Therapeutics Inc. stock is in analyst buy zone - July 2025 Reactions & Free Growth Oriented Trading Recommendations newser.com Sat, 15 Nov 2025 15:16:29 GMT
• Halozyme Announces argenx Received European Commission Approval for VYVGART® Subcutaneous Injection with ENHANZE® for Chronic Infl... Quantisnow Sat, 15 Nov 2025 09:22:29 GMT
• Developing predictive dashboards with Halozyme Therapeutics Inc. data - Gap Down & Weekly Top Performers Watchlists newser.com Sat, 15 Nov 2025 05:19:05 GMT
• Why Halozyme Therapeutics Inc. stock is in analyst buy zone - Trade Entry Report & Smart Money Movement Tracker newser.com Fri, 14 Nov 2025 20:49:38 GMT
• what analysts say about halozyme therapeutics inc stock - short-term trading alerts & free discover massive upside stocks earlytimes.in Fri, 14 Nov 2025 15:36:07 GMT
• will halozyme therapeutics inc. stock benefit from upcoming earnings reports - quarterly trade report & short-term high return ide... Fundação Cultural do Pará Fri, 14 Nov 2025 14:26:41 GMT
• Will Halozyme Therapeutics Inc. (RV7) stock benefit from mergers - Treasury Yields & Consistent Growth Stock Picks Fundação Cultural do Pará Fri, 14 Nov 2025 14:08:48 GMT
• Is Halozyme Therapeutics Inc. (RV7) stock good for long term investing - Swing Trade & Safe Investment Capital Preservation Plans newser.com Fri, 14 Nov 2025 12:09:13 GMT
• Developing predictive dashboards with Halozyme Therapeutics Inc. data - Inflation Watch & Safe Entry Point Identification newser.com Fri, 14 Nov 2025 10:21:20 GMT
• Exit strategy if you’re trapped in Halozyme Therapeutics Inc. - Trade Performance Summary & Daily Market Momentum Tracking newser.com Fri, 14 Nov 2025 04:47:27 GMT
• Strategies to average down on Halozyme Therapeutics Inc. - July 2025 Breakouts & Real-Time Market Trend Scan newser.com Fri, 14 Nov 2025 03:04:55 GMT
• How Halozyme Therapeutics Inc. (RV7) stock reacts to stronger dollar - Earnings Miss & Free Reliable Trade Execution Plans newser.com Fri, 14 Nov 2025 02:14:02 GMT
• Exit strategy if you’re trapped in Halozyme Therapeutics Inc. - Quarterly Profit Summary & High Accuracy Swing Trade Signals newser.com Thu, 13 Nov 2025 22:44:54 GMT
• Why Halozyme Therapeutics Inc. stock is in analyst buy zone - Trade Risk Assessment & AI Based Buy/Sell Signal Reports newser.com Thu, 13 Nov 2025 21:04:48 GMT
• Will Halozyme Therapeutics Inc. stock benefit from upcoming earnings reports - Quarterly Profit Report & Technical Entry and Exit ... newser.com Thu, 13 Nov 2025 14:52:09 GMT
• Developing predictive dashboards with Halozyme Therapeutics Inc. data - Portfolio Growth Summary & Smart Money Movement Tracker newser.com Thu, 13 Nov 2025 12:07:24 GMT
• Is Halozyme Therapeutics Inc. (RV7) stock good for long term investing - July 2025 Earnings & Low Risk Entry Point Guides newser.com Thu, 13 Nov 2025 11:55:32 GMT
• Strategies to average down on Halozyme Therapeutics Inc. - Market Rally & Weekly Market Pulse Updates newser.com Thu, 13 Nov 2025 11:27:20 GMT
• Is Halozyme Therapeutics Inc. (RV7) stock nearing a technical breakout - Quarterly Trade Summary & Weekly Top Gainers Trade List newser.com Thu, 13 Nov 2025 09:39:36 GMT
• Halozyme Therapeutics Insider Sold Shares Worth $4,167,930, According to a Recent SEC Filing MarketScreener Thu, 13 Nov 2025 08:57:59 GMT
• Halozyme Therapeutics CEO Torley sells $4.1m in shares Investing.com Thu, 13 Nov 2025 00:22:10 GMT
• connaughton, director at halozyme, sells $136k in stock by investing.com Investing.com Nigeria Thu, 13 Nov 2025 00:13:39 GMT
• Halozyme Therapeutics completes $1.5 billion convertible notes offering By Investing.com Investing.com Nigeria Thu, 13 Nov 2025 00:09:43 GMT
• Insider Sell: Bernadette Connaughton Sells Shares of Halozyme Th GuruFocus Thu, 13 Nov 2025 00:07:19 GMT
• Connaughton, director at Halozyme, sells $136k in stock Investing.com Wed, 12 Nov 2025 23:43:36 GMT
• Halozyme Therapeutics completes $1.5 billion convertible notes offering Investing.com Wed, 12 Nov 2025 22:36:36 GMT
• Halozyme Therapeutics (HALO): Exploring Valuation Following Strong Q3 Results and Upgraded Guidance simplywall.st Wed, 12 Nov 2025 22:27:14 GMT
• is halozyme therapeutics inc. (rv7) stock dividend growth reliable - 2025 trading recap & scalable portfolio growth methods newser.com Wed, 12 Nov 2025 22:06:24 GMT
• Is Halozyme Therapeutics Inc. (RV7) stock good for long term investing - Gap Up & Daily Oversold Bounce Ideas newser.com Wed, 12 Nov 2025 20:18:31 GMT
• Halozyme Stock Surging On Recent Earnings Beat; Record High Ahead? Investor's Business Daily Wed, 12 Nov 2025 19:40:00 GMT
• how halozyme therapeutics inc. (rv7) stock behaves in tightening cycles - july 2025 gainers & stepwise trade signal implementation... newser.com Wed, 12 Nov 2025 11:59:34 GMT
• halozyme therapeutics shows rising price performance with jump to 82 rs rating Investor's Business Daily Wed, 12 Nov 2025 08:00:00 GMT
• halozyme therapeutics inc rv7 stock analysis and forecast - high dividend yield stocks & small investment trading plans earlytimes.in Wed, 12 Nov 2025 07:34:22 GMT
• how halozyme therapeutics inc. (rv7) stock reacts to stronger dollar - swing trade & community consensus picks newser.com Wed, 12 Nov 2025 06:58:15 GMT
• renaissance group opens new $35m position in halozyme therapeutics (nasdaq: halo): why this biotech stock is worth a look AOL.com Tue, 11 Nov 2025 16:55:23 GMT
• What Halozyme Therapeutics (HALO)'s Raised Guidance and Debt Moves Mean for Shareholders simplywall.st Tue, 11 Nov 2025 16:29:33 GMT
• how halozyme therapeutics inc. (rv7) stock behaves in tightening cycles - market performance report & ai enhanced market trend for... newser.com Tue, 11 Nov 2025 07:39:26 GMT
• Will Halozyme Therapeutics Inc. stock benefit from infrastructure spending - Earnings Overview Summary & Short-Term Swing Trade Al... newser.com Tue, 11 Nov 2025 03:11:50 GMT
• how halozyme therapeutics inc. (rv7) stock reacts to stronger dollar - buy signal & momentum based trading ideas newser.com Mon, 10 Nov 2025 14:16:12 GMT
• strategies to average down on halozyme therapeutics inc. - portfolio risk report & growth focused stock pick reports newser.com Mon, 10 Nov 2025 09:00:43 GMT
• why halozyme therapeutics inc. stock is in analyst buy zone - july 2025 postearnings & real-time volume trigger notifications newser.com Mon, 10 Nov 2025 06:58:35 GMT
• A Look at Halozyme Therapeutics's Valuation Following Upbeat Q3 Earnings and Raised Full-Year Outlook Sahm Mon, 10 Nov 2025 05:45:16 GMT
• What Halozyme Therapeutics (HALO)'s Insider Sales and Diverging Institutional Moves Mean For Shareholders Sahm Mon, 10 Nov 2025 05:29:44 GMT
• renaissance group opens new $35m position in halozyme therapeutics (nasdaq: halo): why this biotech stock is worth a look AOL.com Sun, 09 Nov 2025 12:46:22 GMT
• why halozyme therapeutics inc. stock is in analyst buy zone - 2025 price momentum & low drawdown momentum trade ideas newser.com Sun, 09 Nov 2025 12:04:18 GMT
• exit strategy if you’re trapped in halozyme therapeutics inc. - 2025 market wrapup & expert approved trade ideas newser.com Sun, 09 Nov 2025 11:47:22 GMT
• halozyme announces pricing of $1.3 billion in notes The Globe and Mail Sat, 08 Nov 2025 19:15:22 GMT
• analysts offer insights on healthcare companies: allogene therapeutics (allo), halozyme (halo) and progyny (pgny) The Globe and Mail Sat, 08 Nov 2025 14:03:21 GMT
• halozyme therapeutics announces proposed offering of $650m of convertible senior notes due 2031 and 2032 MSN Sat, 08 Nov 2025 13:24:31 GMT
• halozyme raises 2025 guidance to $1.3b–$1.375b revenue driven by royalty momentum and expands with elektrofi acquisition MSN Sat, 08 Nov 2025 13:02:32 GMT
• latham & watkins advises on halozyme therapeutics’ convertible senior notes offerings totaling us$1.3 billion Legal Desire Media and Insights Sat, 08 Nov 2025 06:23:23 GMT
• Halozyme Therapeutics Stock Sees Improved RS Rating Investor's Business Daily Fri, 07 Nov 2025 18:18:00 GMT
• halozyme therapeutics down after $1.3 bln convertible bonds sale TradingView Fri, 07 Nov 2025 17:54:37 GMT
• halozyme: jnj gets fda approval for new indication of darzalex faspro TipRanks Fri, 07 Nov 2025 13:44:27 GMT
• FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma PR Newswire Fri, 07 Nov 2025 13:30:00 GMT
• halozyme (halo): fda approves darzalex faspro, first and only hr-smm therapy Stock Titan Fri, 07 Nov 2025 13:30:00 GMT
• halozyme therapeutics, inc. announces pricing of convertible senior notes TradingView Fri, 07 Nov 2025 13:05:00 GMT
• halozyme therapeutics prices $1.3 billion private debt offering MarketScreener Fri, 07 Nov 2025 09:22:15 GMT
• Latham & Watkins Advises on Halozyme Therapeutics’ Convertible Senior Notes Offerings Totaling US$1.3 Billion Latham & Watkins LLP Fri, 07 Nov 2025 08:00:00 GMT
• halozyme raises 2025 guidance to $1.3b–$1.375b revenue driven by royalty momentum and expands with elektrofi acquisition MSN Fri, 07 Nov 2025 07:09:05 GMT
• halozyme prices $1.3 billion convertible notes offering Investing.com Fri, 07 Nov 2025 04:52:03 GMT
• will halozyme therapeutics inc. stock benefit from infrastructure spending - july 2025 update & daily price action insights newser.com Fri, 07 Nov 2025 04:50:16 GMT
• halozyme (nasdaq: halo) prices $1.3b convertibles; $87.20 conversion price Stock Titan Fri, 07 Nov 2025 04:43:18 GMT
• halozyme therapeutics, inc. announces pricing of private offering of $650 million of convertible senior notes due 2031 and $650 mi... Sahm Fri, 07 Nov 2025 04:30:00 GMT
• why halozyme therapeutics inc. stock is in analyst buy zone - weekly profit recap & real-time stock price movement reports newser.com Thu, 06 Nov 2025 15:31:54 GMT
• is halozyme therapeutics inc. (rv7) stock dividend growth reliable - 2025 institutional moves & verified entry point signals newser.com Thu, 06 Nov 2025 15:31:22 GMT
• halozyme therapeutics, inc. (nasdaq:halo) just released its third-quarter results and analysts are updating their estimates 富途牛牛 Thu, 06 Nov 2025 11:34:21 GMT
• Halozyme Therapeutics, Inc. (NASDAQ:HALO) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year simplywall.st Thu, 06 Nov 2025 11:30:28 GMT
• will halozyme therapeutics inc. (rv7) stock outperform global peers - cpi data & ai based buy/sell signal reports newser.com Thu, 06 Nov 2025 09:22:12 GMT
• renaissance group opens new $35m position in halozyme therapeutics (nasdaq: halo): why this biotech stock is worth a look sharewise.com Thu, 06 Nov 2025 08:35:22 GMT
• halozyme therapeutics, inc. (nasdaq:halo) q3 2025 earnings call transcript Insider Monkey Thu, 06 Nov 2025 08:14:50 GMT
• what insider trading reveals about halozyme therapeutics inc. stock - weekly investment summary & growth oriented trade recommenda... newser.com Thu, 06 Nov 2025 08:00:57 GMT
• halozyme therapeutics, inc. announces proposed offering of $650 million of convertible senior notes due 2031 and $650 million of c... Sahm Thu, 06 Nov 2025 08:00:00 GMT
• tools to assess halozyme therapeutics inc.’s risk profile - fed meeting & weekly high return stock forecasts newser.com Thu, 06 Nov 2025 07:34:34 GMT
• will halozyme therapeutics inc. price bounce be sustainable - gold moves & high accuracy trade alerts newser.com Thu, 06 Nov 2025 07:07:18 GMT
• will halozyme therapeutics inc. stock see pe expansion - earnings overview report & risk controlled daily trade plans newser.com Thu, 06 Nov 2025 06:42:11 GMT
• halozyme therapeutics announces proposed offering of $650m of convertible senior notes due 2031 and 2032 MSN Thu, 06 Nov 2025 06:20:07 GMT
• why halozyme therapeutics inc. stock could be next big winner - 2025 market wrapup & accurate trade setup notifications newser.com Thu, 06 Nov 2025 04:24:12 GMT
• renaissance group bets $35m on halozyme’s subcutaneous drug delivery disruption NAI500 Thu, 06 Nov 2025 02:40:28 GMT
• will halozyme therapeutics inc. stock benefit from infrastructure spending - july 2025 trends & stock portfolio risk management newser.com Thu, 06 Nov 2025 02:36:01 GMT
• halozyme raises 2025 guidance to $1.3b–$1.375b revenue driven by royalty momentum and expands with elektrofi acquisition MSN Thu, 06 Nov 2025 01:10:39 GMT
• halozyme therapeutics announces proposed offering of $650m of convertible senior notes due 2031 and 2032 MSN Wed, 05 Nov 2025 22:21:56 GMT
• Renaissance Group Opens New $35M Position in Halozyme Therapeutics (NASDAQ: HALO): Why This Biotech Stock Is Worth a Look Nasdaq Wed, 05 Nov 2025 22:12:00 GMT
• halozyme (halo) plans to issue $1.3 billion in convertible notes GuruFocus Wed, 05 Nov 2025 22:08:18 GMT
• halozyme therapeutics, inc. and halozyme, inc. enters into an amendment no. 3 of credit agreement MarketScreener Wed, 05 Nov 2025 22:00:00 GMT
• should you hold or exit halozyme therapeutics inc. now - portfolio performance summary & weekly market pulse alerts newser.com Wed, 05 Nov 2025 21:51:21 GMT
• halozyme therapeutics dips after unveiling $1.3 bln convertible bonds sales TradingView Wed, 05 Nov 2025 21:50:32 GMT
• halozyme announces $1.3 billion convertible notes offering Investing.com Wed, 05 Nov 2025 21:17:04 GMT
• Halozyme Therapeutics, Inc. Announces Proposed Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of C... PR Newswire Wed, 05 Nov 2025 21:05:00 GMT
• halozyme therapeutics (nasdaq: halo) to offer $650m + $650m convertibles in two series Stock Titan Wed, 05 Nov 2025 21:05:00 GMT
• why analysts upgrade halozyme therapeutics inc. stock - inflation watch & ai enhanced trading signals fcp.pa.gov.br Wed, 05 Nov 2025 15:28:26 GMT
• halozyme therapeutics (nasdaq:halo) stock price expected to rise, citizens jmp analyst says MarketBeat Wed, 05 Nov 2025 13:33:28 GMT
• why halozyme therapeutics inc. stock is in analyst buy zone - dividend hike & expert-curated trade recommendations newser.com Wed, 05 Nov 2025 11:38:55 GMT
• combining price and volume data for halozyme therapeutics inc. - july 2025 macro moves & entry and exit point strategies newser.com Wed, 05 Nov 2025 11:17:22 GMT
• how halozyme therapeutics inc. (rv7) stock reacts to stronger dollar - market volume summary & weekly high conviction ideas newser.com Wed, 05 Nov 2025 11:09:07 GMT
• Halozyme Therapeutics (HALO) Profit Margin Jumps to 47.9%, Reinforcing Bullish Narratives simplywall.st Wed, 05 Nov 2025 10:59:01 GMT
• why halozyme therapeutics inc. stock could be next big winner - 2025 key highlights & entry point confirmation alerts newser.com Wed, 05 Nov 2025 10:10:55 GMT
• backtesting results for halozyme therapeutics inc. trading strategies - market activity report & growth oriented trade recommendat... newser.com Wed, 05 Nov 2025 09:58:03 GMT
• strategies to average down on halozyme therapeutics inc. - 2025 macro impact & daily volume surge signals newser.com Wed, 05 Nov 2025 09:56:29 GMT
• halozyme therapeutics reports strong q3 2025 results The Globe and Mail Wed, 05 Nov 2025 09:42:26 GMT
• halozyme raises 2025 guidance after strong q3 results The Globe and Mail Wed, 05 Nov 2025 09:37:34 GMT
• Halozyme Therapeutics (HALO): Exploring the Latest Valuation After Recent Strong Share Price Performance Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
• Will Record Results and the Elektrofi Deal Reshape Halozyme Therapeutics' (HALO) Investment Narrative? Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
• What Recent Analyst Updates Mean for the Evolving Story at Halozyme Therapeutics Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
• will halozyme therapeutics inc. stock benefit from infrastructure spending - 2025 analyst calls & real-time buy zone alerts newser.com Wed, 05 Nov 2025 01:52:31 GMT
• halozyme therapeutics’ earnings call highlights robust growth TipRanks Wed, 05 Nov 2025 00:45:05 GMT
• Citizens Maintains Halozyme Therapeutics (HALO) Market Outperform Recommendation Nasdaq Wed, 05 Nov 2025 00:11:00 GMT
• combining price and volume data for halozyme therapeutics inc. - 2025 investor takeaways & safe capital growth stock tips newser.com Tue, 04 Nov 2025 23:36:44 GMT
• halozyme therapeutics (nasdaq:halo) releases earnings results, beats expectations by $0.09 eps MarketBeat Tue, 04 Nov 2025 21:51:31 GMT
• halozyme raises 2025 guidance to $1.3b–$1.375b revenue driven by royalty momentum and expands with elektrofi acquisition MSN Tue, 04 Nov 2025 21:47:07 GMT
• halozyme q3 2025 slides: royalty revenue surges 52%, guidance raised on strong growth Investing.com Philippines Tue, 04 Nov 2025 19:10:38 GMT
• why halozyme therapeutics inc. stock could be next big winner - july 2025 breakouts & weekly watchlist of top performers newser.com Tue, 04 Nov 2025 14:05:17 GMT
• halo receives maintained rating and raised price target by citiz GuruFocus Tue, 04 Nov 2025 13:54:42 GMT
• h.c. wainwright maintains halozyme therapeutics(halo.us) with buy rating, maintains target price $90 富途牛牛 Tue, 04 Nov 2025 13:31:00 GMT
• hussman strategic advisors inc. grows stock position in halozyme therapeutics, inc. $halo MarketBeat Tue, 04 Nov 2025 11:30:26 GMT
• how halozyme therapeutics inc. (rv7) stock reacts to stronger dollar - july 2025 endofmonth & low drawdown momentum ideas newser.com Tue, 04 Nov 2025 11:17:32 GMT
Halozyme Therapeutics, Inc(NASDAQ:HALO) 
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that ...
Website: http://www.halozyme.com
Founded: 1998
Full Time Employees: 132
Sector: Healthcare
Industry: Biotechnology